P3 Health Partners Inc. (PIIIW) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−3.3x

Market Cap

$39869.60

MomentumView details →

1D Return

−1.61%

YTD Return

+1.00%

RSI (14)

40.6

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−3.3x

Market Cap

$39869.60

RSI (14)

40.6

MomentumView details →

1D Return

−1.61%

YTD Return

+1.00%

ProfitabilityView details →

Gross Margin

31.65%

Net Margin

−6.55%

EBITDA Margin

−5.48%

ROE (TTM)

−136.36%

ROA (TTM)

−15.04%

Asset Turnover

2.26x

GrowthView details →

Revenue YoY

+2.81%

EPS YoY

+26.61%

FCF YoY

−0.34%

Revenue CAGR 3Y

+11.61%

EPS CAGR 3Y

+3.27%

EBITDA YoY

+58.68%

EarningsView details →

EPS (Actual)

−$0.63

EPS Surprise

66.75%

Beats (12Q)

2/12

Next Q EPS Est

−$3.97

Avg Surprise (4Q)

−78.40%

Rev Surprise

2.27%

Capital & dividendView details →

Debt/Equity

1.80x

Current Ratio

0.46x

Quick Ratio

0.46x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

1.50B

Net Income (TTM)

−98.44M

Op. CF (TTM)

−130.52M

Next earningsNov 18, 2026 →

Latest newsMore news →

P3 Health Partners Inc. held its Q2 2026 earnings call on August 10, 2026.25d ago

Similar companies

Talkspace, Inc.TALKW NewGenIvf Group LimitedNIVFW IMAC Holdings, Inc.BACK Mobile-health Network Solutions Class A Ordinary SharesMNDR Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology InstSTLNW ModivCare Inc.MODV Find similar companies →

Latest newsMore news →

P3 Health Partners Inc. held its Q2 2026 earnings call on August 10, 2026.25d ago